Literature DB >> 24814476

Paternal germline mosaicism of a SCN2A mutation results in Ohtahara syndrome in half siblings.

Ayelet Zerem1, Dorit Lev2, Lubov Blumkin3, Hadassa Goldberg-Stern4, Yael Michaeli-Yossef1, Ayelet Halevy4, Sara Kivity3, Kazuyuki Nakamura5, Naomichi Matsumoto6, Esther Leshinsky-Silver7, Hirotomo Saitsu6, Tally Lerman-Sagie8.   

Abstract

Ohtahara syndrome is a devastating early infantile epileptic encephalopathy caused by mutations in different genes. We describe a patient with Ohtahara syndrome who presented on the first day of life with refractory tonic seizures and a suppression-burst pattern on EEG. The patient developed severe microcephaly, and never achieved any developmental milestones. He died at the age of 5 years. A de novo missense mutation (c. 4007C>A, p.S1336Y) in SCN2A was found. Interestingly, the father has another son with Ohtahara syndrome from a different mother. The half brother carries the same SCN2A mutation, strongly suggesting paternal gonadal mosaicism of the mutation. The broad clinical spectrum of SCN2A mutations now includes Ohtahara syndrome. This is the first report of familial Ohtahara syndrome due to a germline mosaic SCN2A mutation. Somatic mosaicism, including germline, has been described in several epileptic encephalopathies such as Dravet syndrome, KCNQ2 neonatal epileptic encephalopathy, SCN8A epileptic encephalopathy and STXBP1 related Ohtahara syndrome. Mosaicism should be considered as one of the important inheritance patterns when counseling parents with a child with these devastating diseases.
Copyright © 2014 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Channelopathies; Early infantile epileptic encephalopathy; Genetic counseling; Mosaic mutation; Suppression-burst

Mesh:

Substances:

Year:  2014        PMID: 24814476     DOI: 10.1016/j.ejpn.2014.04.008

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  5 in total

Review 1.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 2.  NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment.

Authors:  Ana Fernandez-Marmiesse; Sofia Gouveia; Maria L Couce
Journal:  Curr Med Chem       Date:  2018-01-30       Impact factor: 4.530

3.  High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders.

Authors:  Mary Beth Stosser; Amanda S Lindy; Elizabeth Butler; Kyle Retterer; Caitlin M Piccirillo-Stosser; Gabriele Richard; Dianalee A McKnight
Journal:  Genet Med       Date:  2017-08-24       Impact factor: 8.822

4.  Alternative splicing potentiates dysfunction of early-onset epileptic encephalopathy SCN2A variants.

Authors:  Christopher H Thompson; Roy Ben-Shalom; Kevin J Bender; Alfred L George
Journal:  J Gen Physiol       Date:  2020-03-02       Impact factor: 4.086

5.  Do All Roads Lead to Rome? Genes Causing Dravet Syndrome and Dravet Syndrome-Like Phenotypes.

Authors:  Jiangwei Ding; Lei Wang; Zhe Jin; Yuanyuan Qiang; Wenchao Li; Yangyang Wang; Changliang Zhu; Shucai Jiang; Lifei Xiao; Xiaoyan Hao; Xulei Hu; Xinxiao Li; Feng Wang; Tao Sun
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.